/index.html View the latest ���޲�Ʊ����., Ltd. news releases. /news/2025/news202535.html ���޲�Ʊ����'s news release Notice Concerning Results of Tender Offer for Share Certificates, etc., of EcoNaviSta Inc. (Securities Code: 5585) is posted. 2025-05-08T15:30:00+09:00 /news/2025/news202534.html ���޲�Ʊ����'s news release REVENUE OF LEQEMBI® (PRELIMINARY BASIS) is posted. 2025-05-01T19:45:00+09:00 /news/2025/news202533.html ���޲�Ʊ����'s news release ���޲�Ʊ���� Representative Corporate Officer and CEO Haruo Naito Awarded the Order of the Rising Sun, Gold and Silver Star is posted. 2025-04-29T08:30:00+09:00 /news/2025/news202532.html ���޲�Ʊ����'s news release Leqembi® (lecanemab) is the First Medicine that Slows Progression of Early Alzheimer’s Disease to be Authorized in the European Union is posted. 2025-04-16T08:00:00+09:00 /news/2025/news202531.html ���޲�Ʊ����'s news release Update on Regulatory Review of Lecanemab for Early Alzheimer’s Disease by the European Commission is posted. 2025-04-14T21:30:00+09:00 /news/2025/news202530.html ���޲�Ʊ����'s news release Update on Regulatory Review of Lecanemab for Early Alzheimer’s Disease by the European Commission is posted. 2025-04-01T19:00:00+09:00 /news/2025/news202528.html ���޲�Ʊ����'s news release “New Answers to Dementia” ���޲�Ʊ���� Launches Corporate Awareness Campaign is posted. 2025-03-28T11:00:00+09:00 /news/2025/news202527.html ���޲�Ʊ����'s news release EISAI TO DIVEST RIGHTS FOR PARIET® IN CHINA TO PEAK PHARMA is posted. 2025-03-28T08:30:00+09:00 /news/2025/news202526.html ���޲�Ʊ����'s news release ���޲�Ʊ���� to Divest Rights for Warfarin in Japan to Sawai is posted. 2025-03-27T13:00:00+09:00 /news/2025/news202525.html ���޲�Ʊ����'s news release ���޲�Ʊ���� to Present the Latest Research Results, Including Long-Term and Real-Word Data on Lecanemab and Biomarkers for Alzheimer’s Disease at the AD/PD™ 2025 Annual Meeting is posted. 2025-03-27T08:30:00+09:00 /news/2025/news202524.html ���޲�Ʊ����'s news release World’s First Early Alzheimer’s Disease Treatment Developed in Japan LEQEMBI® Receives Prime Minister’s Award at the 12th Technology Management and Innovation Awards is posted. 2025-03-25T10:00:00+09:00 /news/2025/news202523.html ���޲�Ʊ����'s news release EISAI SELECTED AS A NADESHIKO BRAND 2025 AS A LISTED COMPANY EXCELLING IN PROMOTION OF WOMEN IN THE WORKPLACE is posted. 2025-03-24T14:20:19+09:00 /news/2025/news202522.html ���޲�Ʊ����'s news release Proton Pump Inhibitor “Pariet® S” Approved in Japan as RX-to-OTC Switch is posted. 2025-03-21T15:00:00+09:00 /news/2025/news202521.html ���޲�Ʊ����'s news release Notice Concerning Commencement of Tender Offer by ���޲�Ʊ����., Ltd. for Share Certificates, etc., of EcoNaviSta Inc. (Securities Code: 5585) is posted. 2025-03-14T17:35:00+09:00 /news/2025/news202520.html ���޲�Ʊ����'s news release EISAI RECOGNIZED AS “2025 KENKO INVESTMENT FOR HEALTH” FOR THE FIRST TIME AND CERTIFIED AS “OUTSTANDING ORGANIZATION OF KENKO INVESTMENT FOR HEALTH PROGRAM (WHITE 500)” FOR THE SIXTH TIME is posted. 2025-03-10T15:40:00+09:00